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Introduction: In 2015, the UK health secretary made public an intention to include the value 
of medicines costing over £20 on dispensing labels as an attempt to reduce wastage attributable 
to patient behavior. However, there is a lack of evidence investigating the potential effect or 
feasibility of this proposal, and concerns have been raised that it may introduce new problems 
in vulnerable groups. This pilot study aimed to gather views of the Welsh general public on 
this subject.
Methods: Six focus groups from within key population groups were conducted. A snowball 
sampling strategy was employed with participants recruited via a neutral gatekeeper. Focus 
groups session were audio recorded and transcribed verbatim and iterative thematic analysis 
was used to identify emergent themes.
Results: Six focus groups were conducted. Three key themes were identified: “influence of 
cost” – whereby participants expressed concern about cost linking to their perceived value, guilt 
for needing prescribed medication and irrelevance of cost if the medication was considered 
necessary; “knowledge is power” – whereby participants expressed a desire to know more about 
their medicines and engage with health care professionals about them, and felt information on 
dispensing labels alone would be insufficient to support this and “blame the system” – whereby 
participants felt responsibility for wastage should be shared by both system and patient and 
identified existing wasteful practices such as inappropriate prescribing, ordering and disposal 
of returned medicines.
Conclusion: Findings were largely consistent with criticisms publicized by professional 
bodies that introducing cost may serve to make patients feel guilty or unworthy rather than 
encourage them to use their medicines appropriately. Similarly, providing cost information 
on labels alone was considered insufficient and therefore additional counseling or education 
would be necessary to prevent misunderstanding. The acknowledgment of system factors 
contributing to wastage highlights an important role for pharmacists to become involved in 
using medicines more cost-effectively. However, cost was considered irrelevant if the medicine 
was deemed necessary by the patient, and therefore more mindful prescribing of superfluous 
items should be promoted.
Keywords: medicines wastage, cost, adherence, patient perspectives
Introduction
In early 2017, the British Medical Association described the UK’s National Health 
Service (NHS) as being at breaking point.1 Wastage of medicines, defined as medicines 
given to the patient but not consumed,2 is believed to contribute heavily to avoidable 
NHS costs. It is estimated that £300 million worth of medication is discarded in England 
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annually, of which half could potentially be avoided,3 mak-
ing this a topical issue in both medical and political arenas.
Of the existing strategies adopted to reduce medicines 
wastage, Medicines Usage Reviews (MURs), 28-day pre-
scribing and awareness campaigns, have proven to be most 
successful.2 However, as strategies have often been adopted 
in tandem, it is difficult to assess their individual successes, 
and not all initiatives have proven cost-effective.2 Indeed, 
it has been acknowledged instead that a “one-size-fits-all 
approach” is not appropriate for tackling a complex issue 
such as wastage.3
UK patients are largely unaware of the cost of their medi-
cines, as they are either provided free of charge (Northern 
Ireland, Wales or where exemption criteria apply) or subject 
to a standard prescription charge (currently £8.60). Inform-
ing patients of the cost of their medicines through inclusion 
of the price on the dispensing label has, over recent years, 
been sporadically proposed as a novel strategy to encourage 
patients to reconsider wasting their medicines.
However, the literature is not necessarily supportive of 
this proposal. In a report carried out in 2010 by York Health 
Economics Consortium, an expert panel of health care 
professionals and medicine users discussed the inclusion 
of cost on prescription medicines as a strategy for reducing 
wastage. While it was felt useful to make patients more aware 
of the cost of medicines, most medicine users believed that 
the inclusion of costs on labels might possibly deter some 
patients from taking essential treatment, reducing adherence 
and increasing the risk of adverse events.3
Following this report, the Department of Health held a 
roundtable event in 2011 with representatives from patients, 
health care professionals, the NHS and the pharmaceutical 
industry to discuss the findings and identify ways to reduce 
medicines wastage. The inclusion of indicative prices on 
medicine labels was again discussed, but did not receive 
support as concerns were raised that more vulnerable patient 
groups, such as the elderly, might be deterred from taking 
their medications if they believed they were burdening the 
NHS financially.4 Based on these conclusions, the 2012 
government strategy to reduce wastage recommended that 
this proposal should not be pursued further.5
However, despite lack of support or existing evidence 
to indicate effectiveness, in July 2015, the Health Secretary 
Jeremy Hunt unveiled a plan to include the cost of medicines 
costing more than £20 on the dispensing labels, followed by 
the words “funded by the UK taxpayer.”6 He claimed that 
publishing the cost would increase patient responsibility and 
decrease financial strain on the NHS. Response to this has 
been largely negative. The Royal Pharmaceutical Society 
acknowledged that cost may be a factor contributing to patient 
adherence, but as medicines wastage is a multifaceted issue, it 
stated it would require a more complex approach to address.7 
The Patients’ Association expressed concern that patients 
would feel like they are being rationed or a financial burden to 
society at a time when instilling public confidence in the NHS 
is necessary.8 The General Pharmaceutical Council advised 
potential negative consequences needed to be considered and 
advised piloting and testing before implementation.9
The lack of published evidence supporting the policy, 
as well as practical issues for the introduction of a practice 
change, might make the proposal more of a hindrance in the 
future.10 To our knowledge, no evidence currently exists in 
the literature which has piloted this proposal or assessed the 
effectiveness or impact of knowing the medication cost on 
patient behavior. The lack of evidence to support this proposal 
highlights the need for research into its potential impact on 
patient behavior contributing to medicines wastage.
Aims and objectives
This study aimed to explore how making patients aware of 
the cost of their medicines might impact on their behavior 
and medicines usage. The primary objective was therefore to 
explore the views of members of the general public on includ-
ing the NHS cost of prescribed medicines on the dispensing 
label. A secondary objective was to identify key themes to 
inform a national questionnaire to be sent to a wider popula-
tion on this subject.
Methodology
Ethical approval
The Cardiff School of Pharmacy and Pharmaceutical Sci-
ences Research and Ethics Committee granted ethical 
approval for this study on October 23, 2015.
Data collection strategy
A qualitative data collection approach was adopted to allow 
for in-depth analysis of people’s feelings and attitudes. Focus 
groups were selected because they allow participants to 
interact with each other to generate new concepts.
Sample
When selecting participants, it was important to consider 
how the proposal might be received across different popula-
tion groups. Three population groups (students, working age 
adults and senior citizens) were targeted which were likely to 
represent a range of age, educational backgrounds, ethnicities 
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and socioeconomic groups and would additionally be likely to 
include people who either are or have been exposed to others, 
regularly taking medicines for longer-term health conditions. 
By separating groups according to these characteristics, the 
aim was to make participants feel as comfortable as possible 
in expressing their views and also to enable comparisons to 
be drawn between groups during analysis.
Recruitment
Data were collected in October and November 2015. A purpo-
sive snowball sampling technique was adopted by contacting 
a representative of the population group, who then passed 
in the study recruitment information onto others. Potential 
group representatives were contacted via email through a 
neutral gatekeeper (a university staff member). A covering 
letter briefly explaining the study, a participant information 
sheet detailing the study aims and process, and a consent form 
were attached to each email. Participants were required to 
provide written consent by signing the consent form before 
taking part in the study, and were informed that their consent 
could be withdrawn at any time.
Sample size estimation and data 
saturation
Data saturation is reached when analysis produces no new 
emergent themes. As this research had a specific question, 
it was expected that six focus groups would be sufficient to 
provide enough data to answer research questions. This was 
assessed by iterative comparison of emergent themes after 
each focus group was transcribed. The intention was to recruit 
6–12 members per group.11
Focus group format
The participants in each focus group were encouraged to 
discuss their opinions concerning the cost of medicines, 
medicines wastage and their reaction to the proposal to include 
the medication cost on the label of a dispensed medication 
box. Two researchers independently reviewed the literature 
and composed questions and topic areas for the focus group 
discussions. These were then reviewed and discussed with the 
research team, and a collective topic guide was composed. The 
structure of the questions in the guide was semi-structured 
not only to allow flexibility of discussion but also to keep the 
conversation relevant to the study’s aims. Broad, open ques-
tions were used to initiate topics and probing questions, if 
necessary, to steer conversation or to focus discussions. When 
addressing participants’ reaction to the proposal to include 
cost on the label, a selection of labeled medication boxes was 
used as props to facilitate discussion, some of which included 
the cost. Some sample questions are shown in Table 1.
Analysis
The focus groups were recorded using a digital electronic 
voice recording device. Audio recordings were transcribed 
verbatim, and the transcripts were analyzed to identify 
emergent themes. The widely adopted principles of thematic 
analysis12 were used to derive meaningful patterns within 
the data. Two researchers (CJ and TM) independently con-
ducted coding and analysis of the data to generate themes. 
All interpretations made from the data were then reviewed 
and discussed together with the research team to confirm 
all valid themes had been recognized and to further refine 
themes where necessary. Any disagreements or differences 
in interpretation were discussed as a team and compromise 
reached by referring back to the original transcripts.
Data processing and conidentiality
All data collected was processed and stored anonymously 
with all identifying information relating to participants 
removed. For the purpose of the study, participants were 
allocated a unique study reference number, which was used 
for the duration of the study. To ensure the study was trust-
worthy, Lincoln and Guba’s13 evaluative criteria were taken 
into consideration throughout.
Table 1 Sample questions from inal topic guide
Subject area Broad questions Probing questions
Awareness of cost Can you tell me anything different you notice 
about these boxes of medicines?
How do you feel about the cost being displayed?
Does the cost surprise you? Why/not? What do you understand 
by the term “cost to NHS”?
Does it interest you to know the cost? Why/not?
Interpretation of cost What do you think it means if a medicine is 
expensive?
What might you do differently knowing the cost 
of your medicine?
Does it change your opinion of the medicine?
Would it make you more likely to take the medicine?
Would it encourage you to discuss cost with your GP/
pharmacist/other?
Abbreviations: GP, general practitioner; NHS, National Health Service.
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Results
A total of 34 participants took part in six focus groups. No 
person who was approached to participate refused to take 
part. The demographics of each group are summarized in 
Table 2. Each focus group lasted between 1 and 1.5 hours.
Table 3 shows key quotations from participants arranged 
by theme.
Theme 1: inluence of cost
There was a general consensus across groups that if a medi-
cine is deemed “necessary,” whether by the patient or their 
prescriber, or because of the condition it is being used for, 
then it should be taken irrespective of the cost (Table 3, 
quote A). In these instances, participants argued that telling 
patients the cost of their medicines would only serve to make 
them feel guilty about needing it (Table 3, quote B).
Participants in the elderly groups in particular felt that 
their general practitioners (GPs) always prescribe the cheap-
est available medication, and there was a consensus among 
participants that cheaper medicines are generally less effec-
tive (Table 3, quotes C and D). This belief was largely based 
on their own experiences of having started on one medication 
and then being changed on to another because it was found 
to be unsuitable or ineffective. Participants across the groups 
felt that being told they were taking a lower-cost medication 
might make them feel short-changed or devalued (Table 3, 
quotes E and F). In addition, participants felt some patients 
may believe the value of their medication is linked to their 
Table 2 Focus group demographics
Focus group Participants (n) Male, % (n) Demographics
1 5 20 (1) Senior citizens aged over 65 years
2 5 20 (1) Senior citizens aged over 65 years
3 6 17 (1) Senior citizens aged over 65 years
4 7 57 (4) Non-pharmacy and pharmacy university staff and postgraduate students
5 6 33 (2) Non-pharmacy students, aged 18–23 years
6 5 20 (1) Non-pharmacy students, aged 18–23 years
Table 3 Key quotations displayed by theme
Theme 1: Inluence of cost Theme 2: Knowledge is power Theme 3: Blame the system, not me!
A “When they’re keeping you alive then you’re 
going to take them aren’t you, whatever the cost!” 
E2P2
B “There’s no point in blackmailing me about the 
cost if that’s what my professional says is what I’ve 
got to take” E2P5
C “Some people would demand the dearer ones 
because they think it would do them better” E2P3
D “You would assume that because one is more 
expensive that it would work better, wouldn’t you? 
If it’s more expensive then it must be a better 
product” SP3
E “If you start telling a patient on a regular basis 
‘do you know how much this costs’, that there is a 
real risk that that patient feels... that they are not 
worth that drug” AP7
F “As you start to bring cost in there is a 
perception by patient... that you don’t care about 
them and you’re just trying to give them something 
cheap” AP1
G “The reasons you would not take a medicine is 
either because you forget - and knowing the cost 
won’t make your memory better - or because you 
don’t need it anymore” AP2
H “It’s about putting things into context for the 
patient and the patient understanding exactly the 
beneits of what they’re taking and having that 
really good patient-centred conversation” SP3
I “If you’re going to have a proper discussion 
about [wastage] it should be via a conversation, 
not via sticking something on a label” AP3
J “The more direct the link with a positive effect, 
the less problem of wastage there would be, and 
that comes down to education” AP1
K “The price I think is interesting for people to see 
how much they are costing the health service or 
how much they’re getting back of their tax” E1P3
L “I’d like to be informed and think ‘yes I am on 
an expensive item for the surgery’ but they’re 
willing to keep me going, especially when it oil 
adds up” E1P2
M “If you force thinking about cost in that way 
the end result is that you undermine the patient’s 
conidence in the integrity of their medical 
practitioners” AP4
N “They’re free so they order them even if they don’t 
use them” E1P1
O “I think there’s a separation between where the 
money for the drugs comes from and the fact that 
you’re getting them for free. You don’t always make 
the link between the fact that they have to be paid 
for by someone, somehow” SP1
P “In Wales we’re not putting our hands in our 
pockets and paying for that prescription so we don’t 
take as much ownership because we’re not wasting 
our money” AP5
Q “What we actually do at the moment is we just 
keep piling more medicines on, oh here’s another one, 
here’s another.... And that creates waste” AP3
R “There must be enormous amounts of stockpiling 
because people keep going for their repeat 
prescriptions because it’s free the doctor signs it off 
and it keeps coming” SP6
 
In
te
gr
at
ed
 P
ha
rm
ac
y 
Re
se
ar
ch
 a
nd
 P
ra
ct
ice
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
25
1.
25
4.
47
 o
n 
27
-O
ct
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
Integrated Pharmacy Research and Practice 2017:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
177
Displaying costs on dispensing labels to reduce wastage
perceived worth by the health care professional, which could 
either improve or undermine their trust in the health care 
system, depending on whether they considered they were 
getting good value for money (Table 3, quotes K to M)
However, participants generally believed that prescribers 
had the expertise and the best intentions to prescribe the most 
appropriate medicine for them, and so ultimately participants 
felt it was important to trust their decision in what they have 
chosen to prescribe (Table 3, quote B). Participants across 
all groups felt that the cost had less of an impact on their 
decision to take a medication compared to the advice given to 
them by their health care provider. It was also acknowledged 
that cost would not have an influence on causes of wastage 
such as unintentional non-adherence or changes to regimens 
based on clinical needs (Table 3, quote G).
Theme 2: knowledge is power
Across all groups, participants expressed a general lack of 
knowledge of how the NHS funds medications, how the 
taxpayer pays for medicines and what the standard prescrip-
tion charge represents. Participants suggested that patients 
might like to be better informed about the funding and cost 
of their medicines (Table 3, quotes K to M), which may lead 
them to feel more empowered to adjust their medication 
taking and ordering behaviors accordingly. In line with this, 
participants suggested that stating the cost followed by the 
words “funded by the UK taxpayer” on dispensing labels is 
not a clear enough statement on its own to convey the correct 
message and that either verbal or written explanation by the 
pharmacist would be necessary for them to fully understand 
its meaning.
Participants expressed an interest to learn more about 
their medicines generally, not just how much they cost, and 
this was suggested as a method by which adherence could 
be improved. The participants discussed promoting open 
communication channels between the patient and prescriber 
in an attempt to collaboratively make decisions and improve 
understanding (Table 3, quotes H and J).
Participants felt that improving the knowledge of the med-
icines they are taking, and why, may help them to understand 
whether or not they need them and whether they can avoid 
wasting them. MURs were suggested as platform for this. 
However, concerns were raised, especially by participants in 
the working age adult group, that opening a discussion about 
cost with a patient might make the patient feel uncomfortable, 
guilty or lead them to believe that cost savings are being pri-
oritized over the quality of their care, and thus undermine the 
integrity of the health care professional (Table 3, quote M).
There was a general feeling across all groups that using 
the dispensing label would be an ineffective medium to com-
municate information about wastage (Table 3, quote I), as 
when looking at medication boxes participants demonstrated 
that it is not always noticed, and often boxes are immediately 
discarded, let alone carefully read or considered. Participants 
argued that any effect of showing the price would be short-
lived as people would become accustomed to seeing it.
Theme 3: blame the system, not me!
The idea of responsibility for wastage was a recurrent theme 
within discussions. Participants argued that this proposal 
puts the responsibility for wastage primarily on the patient, 
and there was feeling among all participant groups that 
patient behavior was not the sole cause of wastage, and the 
responsibility should be shared by the prescriber and health 
care system as well. For example, the practicalities of poly-
pharmacy and the idea that adherence would always be poor 
where patients are prescribed a complicated, impracticable 
regimen were discussed. In addition, the concept of unavoid-
able waste was discussed, such as when a patient dies or the 
regimen changes such that medicines are no longer needed, 
for which the patient cannot be held responsible.
Participants indicated how easy it is to over-order medica-
tion through the current pharmacy repeat prescription service, 
facilitating stockpiling, and the perceived lack of monitoring 
of this process (Table 3, quotes N and O). Some participants, 
particularly in the student and elderly groups, were unaware 
that even unused medicines returned to pharmacies have to be 
destroyed, and participants across all groups were concerned 
about the cost implications of this. It was also highlighted that 
people who are not paying for medication directly – such as 
Welsh residents or those meeting exemption criteria – might 
not be concerned about the financial impact of ordering them 
(Table 3, quotes P to R).
Discussion
Main indings
The general reaction to displaying the medication cost on the 
dispensing label was negative, with participants feeling that 
it alone would be insufficient to convey the correct meaning, 
may serve more to reprimand patients for needing medicines 
rather than encourage them to be used appropriately and 
would not be as effective in improving patient adherence 
as education and engagement. This is consistent with the 
sentiment of both the Royal Pharmaceutical Society’s and 
Patient’s Association public responses to this proposal,7,8 
in which patient empowerment and understanding were 
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 considered equally relevant as cost in whether a patient takes 
their medication as prescribed.
Strengths and limitations
In terms of strengths, this study has provided insight into the 
general public’s potential response to the proposal to include 
the cost on dispensing labels, which to our knowledge no 
previous research study has attempted. Our findings have 
provided key themes which can now be used inform a national 
questionnaire to the general public to provide more detailed 
scope of this topic.
The study explored members of the public’s hypotheti-
cal response to the proposal, but this may not be reflective 
of how their actual response or behavior may be affected 
in practice. This can only be known through piloting the 
implementation of this proposal. Our study was relatively 
small, and participants were all living in the local area of 
Cardiff in Wales. Participants recruited for the working-age 
adult group were all university staff members, and thus all 
educated to degree level, and so may their views may not be 
representative of the general population. Similarly, a higher 
proportion of female participants were included in our focus 
groups, which may have affected results. Aside from these, 
individual characteristics for participants were not identified 
as part of the recruitment process. The participant character-
istics were aspirational; therefore, we cannot say for certain 
if the collective group of participants was indeed diverse as 
intended. However, it is apparent from the data that a diverse 
range of experiences and opinions was demonstrable across 
the participants, providing rich data.
Practice implications
Concerns have been raised3–5,7,8 that knowing the cost of medi-
cines may put some patients off taking them as prescribed, 
either due to them feeling the medicines were too costly to be 
justified, or too cheap to be considered effective. Consistent 
with the literature, our findings showed that the latter was 
indeed a concern, especially in elderly populations, who 
believed that cost was an indicator of effectiveness. This is a 
common misconception among the general public, as many of 
the most clinically effective medicines are those that are long 
established in the market and so considerably cheaper. This 
finding indicates that the proposal to display only the price of 
medicines costing £20 and over might be sensible, as patients 
would not know if their medicine was particularly inexpensive 
and this would not affect their perception of its clinical efficacy.
However, participants felt that if their medicines were 
deemed to be necessary, knowing the cost of their  medicines 
would not affect whether they ordered or took them as 
prescribed. It follows then that more could be done to help 
patients understand which of their medicines are indeed nec-
essary, and which could be used less, on an ad hoc basis, or 
even purchased instead of prescribed. Similarly, the prescrib-
ing of medicines considered superfluous could be avoided 
altogether. In England, some clinical commissioning groups 
have introduced restrictions on prescribing of medicines 
which can be purchased over the counter14 and the Choose 
Well national initiative in Wales encourages patients to access 
the appropriate service based on their ailment, avoiding 
unnecessary GP appointments and prescribing.15
Patient engagement
Participants’ suggestion to increase outreach to patients by 
GPs and pharmacists on the subject of cost and wastage is 
consistent with the literature that the most effective method 
to increase adherence is through patient-centered models that 
increase patient understanding and involvement in decisions 
surrounding their health.1,16–20 However, our findings suggest 
that engaging with patients about the cost of their treatment 
could be a delicate matter that, if handled inappropriately, 
might cause patients to believe their care is being compro-
mised to save costs, which would undermine confidence or 
trust in the health care professional. Any discussions on this 
subject would therefore need to be conducted sensitively, 
possibly with the provision of adequate staff training in place.
Our results indicate that, in order for this proposal to 
be safe, preventative action should be taken by health care 
professionals to reduce the risk of misunderstanding or 
patients being deterred from taking medicines. Participants 
suggested the provision of written information, such as a 
leaflet, should be provided alongside dispensed medicines to 
educate patients about the cost and what it means. This could 
also be used to explain funding of medicines in the NHS, a 
topic on which participants indicated they lacked knowledge. 
However, written information may be insufficient as there is 
no guarantee that the patient reads and understands what is 
provided, and there is evidence that a combination of writ-
ten information and verbal counseling is more effective in 
improving patients’ understanding of their medicines.16,21
However, available pharmacist time is a concern, and 
in spending time with patients explaining cost, the time 
spent counseling on the medication itself may be reduced.10 
Alternative patient-facing methods, perhaps involving a 
GP practice-based pharmacist or increasing the scope of 
pharmacy-based MURs to include raising awareness of cost, 
might instead be worth further investigation.
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Improving the system
Many participants believed that the health care community 
itself could reduce medicines wastage by reviewing policies 
on polypharmacy, prescribing quantities, repeat prescriptions 
and the fate of medications returned to the pharmacy. In 2007, 
a UK study of returned medicines found that one-quarter of 
unused medication boxes returned to pharmacies and GP sur-
geries would be suitable for reuse,22 and our findings indicate 
that the public might be amenable to such initiatives. A smaller 
UK study in 2005 found that after a change in regimen, the 
second most common reason for returned medication was a 
clear out of accumulated medicines in the home, caused in 
part by over-ordering or supply of prescription items.23 These 
studies also found that a large proportion of returned items 
were due to potentially predictable causes and suggested that 
ensuring appropriate supply quantities might help to reduce 
the number of wasted medicines. Similarly, regular updat-
ing of the repeat ordering slip and deletion of inappropriate 
or unnecessary items could avoid excessive reordering and 
stockpiling behavior.24 An improvement in these areas may be 
demonstrated in the near future with the increasing emergent 
roles of pharmacists working in GP practices to optimize pre-
scribing, who can also play a role in promoting cost-conscious 
and efficient medicines usage by patients.
Conclusion
While a need to improve general awareness of cost and 
NHS funding of medicines among patient groups has been 
identified, results indicate that this information alone will not 
encourage a significant change in behavior. Further support 
to accompany this proposal as a practice change is necessary 
to avoid any patient misunderstanding and negative effects 
associated with feeling undervalued or guilty about the cost 
of their medication. Results instead indicate it would be more 
effective to treat the causes of wastage such as poor adherence 
and inappropriate prescribing and to engage effectively with 
patients about their medicines to help them to understand 
how to use them appropriately.
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